Heidi Cuthbert

North Stawell Minerals (ASX:NSM) has commenced a 2,000–2,500-metre air core drilling program at its Caledonia and Darlington projects.

Imugene (ASX:IMU) announced exceptional clinical data from the CAR T-naïve cohort of its ongoing Phase 1b basket study of azer-cel.

Clarity Pharmaceuticals (ASX:CU6) has exceeded recruitment targets for its registrational Phase 3 AMPLIFY trial in just nine months.

Lode Resources (ASX:LDR) commenced a high-priority, 32-hole drilling program at its flagship Uralla Gold Project.

Franco-Nevada (NYSE:FNV), the gold-focused royalty and streaming company, reported record-breaking financial results for the fiscal year ended December 31, 2025.

Laser Photonics (NASDAQ:LASE), a leading industrial developer of high-power laser systems for cleaning and material processing, announced preliminary, unaudited financial results for the fiscal year ended December 31, 2025.

Ideal Power (NASDAQ:IPWR), the pioneer behind the highly efficient and broadly patented B-TRAN® bidirectional semiconductor power switch, reported fourth-quarter and full-year 2025 financial results on Tuesday.

ADC Therapeutics (NYSE: ADCT), a commercial-stage biotechnology company improving the lives of cancer patients with its next-generation antibody-drug conjugates (ADCs), reported a steady fourth quarter for 2025 and a significantly strengthened balance sheet on Tuesday.

Apyx Medical (NASDAQ:APYX), an advanced energy technology company proprietary to the Renuvion® helium plasma platform, reported a net loss of $1.3 million for its fourth quarter on Tuesday.

ABM Industries (NYSE:ABM), a global leader in facility services and integrated solutions, reported a solid start to its fiscal year 2026 on Tuesday, with first-quarter revenue reaching $2.2 billion.